Test Price
2,800 AED✅ Home Collection Available
UAE Certified Genetic Testing · ISO 9001:2015 · DHA-Licensed
SPAST Gene (SPG4) Next-Generation Sequencing (NGS) Genetic Test in UAE 2800 AED · Advanced Molecular Diagnostics
Executive Summary & Core Metrics
Clinical Safety and Service Highlights
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Sequencing and Bioinformatic Validation.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post‑Test Clinical Interpretation with our Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 before collection.
Compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Test Overview & Methodology
The SPAST Gene SPG4 Genetic Test is a comprehensive analysis designed to detect pathogenic mutations in the SPAST gene, the most common cause of autosomal dominant hereditary spastic paraplegia (HSP‑SPG4). Performed on blood, extracted DNA, or FTA card samples, this test delivers definitive molecular diagnosis with a turnaround time of 3‑4 weeks.
| Feature | Our Test (NGS) | Traditional Sanger Sequencing |
|---|---|---|
| Precision | Full gene coverage, detects single nucleotide variants, indels, and copy number changes | Targeted analysis of known mutations only |
| Method | Next-Generation Sequencing with Sanger confirmation of pathogenic variants | Sanger sequencing of select exons |
| Speed | 3‑4 weeks | 6‑8 weeks |
Physician Insight & Safety Protocols
“At our center, we understand that facing a possible hereditary neurological condition is deeply personal. As a Consultant Medical Geneticist, I want to reassure you that a positive SPAST result provides clarity and opens the door to targeted management and family planning. However, genetic results must always be correlated with your clinical picture and neurological examination. Please never adjust or discontinue any medication without consulting your physician. We are here to guide you through every step.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Patient Safety Exclusion Criteria & Red Flags
- Exclusion Criteria: Individuals under 18 without parental/guardian consent (per Federal Law No. 2 of 2019 and PDPL); known acute infection interfering with sample collection; pregnancy for predictive testing must be disclosed.
- Emergency Red Flags: If you experience acute onset of leg paralysis, severe muscle stiffness with inability to walk, or sudden vision loss, seek emergency medical care immediately—this test is not for emergency diagnosis.
Medication Advisory
Do not discontinue or adjust any prescribed medication without consulting your treating physician. Genetic results do not replace clinical judgment.
Patient FAQ & Clinical Guidance
1. What is the SPAST gene SPG4 Genetic Test used for?
Our test uses NGS to identify SPAST gene mutations, confirming hereditary spastic paraplegia type 4 diagnosis with 99.9% sensitivity. It helps neurologists differentiate SPG4 from other movement disorders and informs family risk assessment.
2. How is the sample collected for the SPAST gene test?
A VIP mobile phlebotomist collects blood or one drop on FTA card at home under strict cold‑chain conditions. You can choose a conventional whole blood draw, extracted DNA submission, or a painless finger‑prick FTA card, all handled by our DHA‑licensed mobile team.
3. What should I do after receiving my SPAST gene test results?
Schedule a telephonic consultation with our Consultant Medical Geneticist for expert result interpretation and next steps guidance immediately. Together, we will review the clinical significance of any variant found and create a personalized management or family screening plan.
UAE Regulatory & Data Privacy Adherence
Data Protection & Healthcare Compliance
This testing service operates in full compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, and consent protocols follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. Your genetic information remains confidential and is used exclusively for diagnostic purposes.
Clinical & Logistical Metadata
| Test Name | SPAST Gene (SPG4) Next-Generation Sequencing (NGS) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA), extracted DNA, or FTA card sample |
| Methodology Used | Next-Generation Sequencing with Sanger confirmation of pathogenic variants |
| ICD-10-CM Code | G11.4 (Hereditary spastic paraplegia) |
| LOINC Code | 95803-7 (SPAST gene full gene sequencing) |
| DHA Facility License & Address | DHA License No. 1143 · Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE · DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians